Emergency heart attack care

NEW YORK, July 7 (Praxis Press) Prompt treatment of heart attacks is crucial to the survival of the patient. Two important treatments that require trained emergency medical personnel and need to be administered as quickly as possible are drugs to dissolve clots (thrombolytic agents) and defibrillation and other methods to control heart arrhythmias. Rapid access to emergency medical care is a problem in many communities and even when the decision is made to seek medical care, most patients in the


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

NEW YORK, July 7 (Praxis Press) Prompt treatment of heart attacks is crucial to the survival of the patient. Two important treatments that require trained emergency medical personnel and need to be administered as quickly as possible are drugs to dissolve clots (thrombolytic agents) and defibrillation and other methods to control heart arrhythmias. Rapid access to emergency medical care is a problem in many communities and even when the decision is made to seek medical care, most patients in the US avoid ambulance service, preferring to get to the hospital themselves. A recent study evaluated the effect of a community-wide education program designed to decrease delay in access to medical care for patients with heart attacks. Use of emergency medical services by patients with chest pain increased significantly in communities that received the intervention, but there was no difference in the change in delay time from symptom onset to hospital ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide